Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for developing CRISPR-Cas9 genome editing.
On October 7, 2020, the Royal Swedish Academy of Sciences announced that Jennifer Doudna and Emmanuelle Charpentier would jointly receive the Nobel Prize in Chemistry "for the development of a method for genome editing" — the CRISPR-Cas9 system.
This announcement marked a historic first: it was the first time a Nobel Prize in the sciences had been awarded to a team composed entirely of women, a landmark moment for gender representation in science, which has historically been dominated by male laureates. Doudna and Charpentier's collaboration, which began at a conference in Puerto Rico in 2011, led to their seminal 2012 Science paper demonstrating that Cas9 could be programmed with a single guide RNA to cut DNA at any desired location.
The Nobel Committee recognized that this discovery had revolutionized the life sciences, providing scientists with unprecedented precision, speed, and simplicity in editing the genomes of plants, animals, and microorganisms, with far-reaching applications in agriculture, biotechnology, and the treatment of genetic diseases, including sickle cell disease and certain cancers.
The award represented the pinnacle of scientific recognition for a discovery that, in less than a decade, had transformed from a bacterial immune defense mechanism into one of the most widely used and transformative tools in modern biology, with Doudna herself becoming one of the most publicly recognized scientists of her generation.